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The aim of this study was to explore the association between polymorphisms in signal transducer and activator of transcription
protein 3 (STAT3) and the risk of gastric cancer. In the present study, a case-control study was conducted in which rs2293152 and
rs744166 polymorphisms in STAT3 were analyzed in 209 Chinese patients with gastric cancer and 294 cancer-free controls. The
genotypes were determined by polymerase chain reaction restriction fragment length polymorphism method. For the rs744166
polymorphism, the TC genotype (adjusted OR = 0.60, 95% CI = 0.39–0.92, and 𝑃 = 0.020) and CC genotype (adjusted OR = 0.41,
95%CI = 0.21–0.80, and𝑃 = 0.009) were associated with a decreased risk of gastric cancer compared to the TT genotype. However,
rs2293152 did not show any difference in gastric cancer risk between patients and controls in the CG/CC genotype compared to
the GG genotype. Besides, the SNP effects were additive to the effects of environmental factors without any interaction between
them in the susceptibility to gastric cancer. Collectively, rs744166 polymorphismmight be significantly associated with a decreased
risk of gastric cancer in a Chinese population. Additionally, polymorphisms in STAT3, along with environmental factors, might be
associated with the development of gastric cancer.
1. Introduction
In recent years, gastric cancer (GC) incidence rates have
decreased substantially in most parts of the world. However,
GCwas still the fourthmost commonmalignancyworldwide,
with approximately 989,600 new cases, particularly in Eastern
Asian countries, such as China [1, 2]. It is well known that the
development of GC is a multifactorial process that includes
both host polymorphisms and environmental factors [3].
Signal transducer and activator of transcription 3
(STAT3) is a key transcription factor of the Janus kinase
(JAK)/signal transducer and activator of transcription
(STAT) signaling pathway [4, 5]. The JAK/STAT pathway
transmits a wide range of regulatory factors that modulate
gene transcription, including cytokines, growth factors, and
hormones [6]. In particular, STAT3 can be activated by a
variety of ligands that respond to massive signals such as
IL-6, TNF-𝛼, and VEGF [4, 5, 7, 8]. Aberrant expression and
constitutive activation of STAT3 are involved in a broad range
of human malignancies, including gastric, breast, prostate,
and nonsmall cell lung cancers [9–12]. Recent studies have
identified STAT3 activation as a key event in regulating
cell growth, motility, migration, invasion, angiogenesis,
and immune response in GC [8, 9, 13–17]. Furthermore,
it was reported that Helicobacter pylori (H. pylori) CagA
protein activated the STAT3 signaling pathway in gastric
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cells, providing a potential mechanism by which chronic H.
pylori infection promotes the development of GC [18, 19].
STAT3 is located on chromosomal region 17q21. To
date, single-nucleotide polymorphisms (SNPs) in STAT3
have shown significant associations with cervical cancer,
nonsmall cell lung cancer, leukemia, prostate cancer, and
hepatocellular cancer [20–24]. Ferguson et al. also found that
STAT3 SNPs are significantly associated with susceptibility
of Crohn’s disease [25]. To our knowledge, no studies have
been published to explore the association between STAT3
polymorphisms and GC risk until now.
In this case-control study we aim to evaluate the associ-
ations between STAT3 polymorphisms and susceptibility of
GC, as well as discussing potential environmental factors.
2. Materials and Methods
2.1. Study Subjects. A case-control study was conducted
using a Chinese study population of 209 GC patients and
294 controls. All patients, based on pathologic diagnosis,
were recruited from the Third Affiliated Hospital of Harbin
Medical University. For the frequency-matched controls on
age and sex, 154 healthy individuals were recruited from
Harbin Center for Disease Control, as well as 140 cancer-free
patients who were chosen from the neurology department at
the Fourth Affiliated Hospital of Harbin Medical University
as controls. All cases and controls had completed a face-
to-face questionnaire. A 5mL sample of venous blood was
collected from each subject following the interview. Cases
and controls with incomplete questionnaires, as well as
non-GC patients, were excluded from this study. Informed
consent was obtained from all subjects and the protocol was
approved by the Human Research and Ethics Committee of
Harbin Medical University.
2.2. Data Collection. Demographic and habit related data
such as age, gender, smoking (including cigarette and pipe)
and drinking history, family history of cancer, and frequency
of food consumption were collected using a structured
questionnaire. We defined smokers as those who smoked
more than one cigarette/pipe per day for at least half a year.
Likewise, drinkers were defined as those who consumed two
or more alcoholic drinks per week for at least half a year. For
family history, it referred to first and second degree relatives
(parents, grandparents, siblings, and offspring).
2.3. SNP Selection and Genotyping. Genomic DNA was
extracted from whole blood using a QIAamp DNA Blood
Mini Kit (Qiagen, Germany). DNApurity and concentrations
were determined by spectrophotometric measurement of
absorbance at 260/280 nm.
STAT3 gene polymorphisms were reviewed based on
previously published literature which identified functional
effects or associations with disease. Minor allele frequency
(MAF) of ≥5% in the Asian population, parameters set by
the SNP database of the National Center for Biotechnol-
ogy Information, were also reviewed. Ultimately, rs2293152
(G>C) and rs744166 (T>C) polymorphisms were selected.
Polymerase chain reaction restriction fragment length
polymorphism (PCR-RFLP) was implemented to determine
the genotypes. The PCR primers were designed using Primer
Premier 5.0 software. For rs2293152, the primer sequences
were 5󸀠-TAGAGGCTTCCTTTTGTTCCG-3󸀠 (forward) and
5󸀠-CCAGTTGTCTTTCATCCC-3󸀠 (reverse) that generated
the 356-bp fragment. For rs744166, the primer sequences
were 5󸀠-GAGTACAAACCCTGAACC-3󸀠 (forward) and 5󸀠-
GACTTGGTGACTGACTGAA-3󸀠 (reverse) that generated
the 301-bp fragment. Amplification was performed under
the following conditions: an initial denaturation for 5min
at 95∘C, followed by 30 cycles of denaturation at 95∘C for
30 s, annealing at 56∘C for 30 s, and extension at 72∘C for
30 s, followed by a final extension at 72∘C for 7min. The
amplified fragments of STAT3 rs2293152 and rs744166 were
digested by restriction enzymes AciI and AluI (New England
BioLabs), respectively, 5 units for 16 h at 37∘C, followed by
electrophoresis on a 2% agarose gel.
We used the common genotype homozygotes, the rare
genotype homozygotes, and the heterozygous of the polymor-
phisms (rs2293152 and rs744166) for direct sequencing.
2.4. Statistical Analysis. A chi-square (𝜒2) test was used
to evaluate Hardy-Weinberg equilibrium (HWE), as well
as comparing the genotype and allele frequencies between
groups. The associations between genetic polymorphisms
and the risk of GC were estimated by computing the odds
ratios (ORs) and their 95% confidence intervals (CIs) from
unconditional univariate and multivariate logistic regression
analyses. We evaluated the interactions between genetic
polymorphisms and environmental factors on the risk of
GC with four types of ORs (ORe, ORg, OReg, and ORi).
Reference groups consisted of individuals who were not
exposed to environmental factors and lacked genetic variants.
ORe compares the risk of GC based on the level of exposure
to environmental factors; ORg is the odds ratio for the
association between the genetic variant with the risk of
GC; OReg is the odds ratio for the combined effect of both
genetic variants and environmental factors; ORi is the odds
ratio of interactions of genetic variants and environmental
factors. (ORi = OReg/OReORg, ORi > 1 indicated a posi-
tive interaction (synergy); ORi < 1 indicated a negative
interaction (antagonism); ORi = 1 indicated that there was
no interaction.) A 𝑃 value of <0.05 was considered statisti-
cally significant. All tests were two-sided, and all statistical
analyses were conducted with SAS 9.1 (SAS Institute, Cary,
North Carolina, USA).
3. Results
3.1. Characteristics of Study Subjects. This case-control study
enrolled 209 GC patients and 294 cancer-free controls. The
demographic information on study subjects are shown in
Table 1. There were no significant differences between cases
BioMed Research International 3
Table 1: Baseline characteristics of study subjects.
Characteristics
Cases
(𝑁 = 209)
Controls
(𝑁 = 294) 𝑃 value∗
No. (%) No. (%)
Age (years) 0.331
<60 106 (50.7) 162 (55.1)
≥60 103 (49.3) 132 (44.9)
Sex 0.076
Male 158 (75.6) 201 (68.4)
Female 51 (24.4) 93 (31.6)
BMIa (kg/m2)
Mean ± SD
22.4 ± 3.8 24.2 ± 3.3
<0.001
Smoking statusa <0.001
Never 71 (34.1) 154 (52.6)
Ever 137 (65.9) 139 (47.4)
Alcohol consumption <0.001
Nondrinkers 85 (40.7) 172 (58.5)
Drinkers 124 (59.3) 122 (41.5)
Family history of cancerab <0.001
No 157 (77.0) 280 (95.9)
Yes 47 (23.0) 12 (4.1)
TNM stagea
I 14 (7.3)
II 15 (7.8)
III 142 (74.0)
IV 21 (10.9)
BMI: body mass index (weight/height2).
∗
𝑃 value from two-sample 𝑡 tests and 𝜒2 tests.
aMissing data: BMI: 7; smoking: 2; family history of cancer: 7; tumor site: 17.
bFamily history of cancer: gastric, esophageal, liver, colorectal, and other
cancers.
and controls in the distributions of age and sex (𝑃 > 0.05).
However, smoking and drinking were overrepresented in the
cases compared to the controls (𝑃 < 0.001), and cases with
family history of cancer were more frequent than controls
(𝑃 < 0.001).
3.2. Association between STAT3 Polymorphisms and GC. In
our study population, the alleles at rs2293152 and rs744166
loci were in HWE (𝑃 = 0.233 for rs2293152 and 𝑃 = 0.851
for rs744166). The genotype distributions of these two SNP
loci in the cases and controls are presented in Table 2. The
distributions of the genotypes for STAT3 rs744166 were 9.1%
(TT), 42.6% (TC), and 48.3% (CC) in the cases and 36.4%
(TT), 48.3% (TC), and 15.3% (CC) in control subjects (𝑃 =
0.01). Additionally, STAT3 rs744166 showed a statistically
significant association in further logistic regression analysis.
Compared to the TT genotype carriers, the TC genotype
(adjusted OR = 0.60, 95% CI = 0.39–0.92, and 𝑃 = 0.020)
and CC genotype (adjusted OR = 0.41, 95% CI = 0.21–0.80,
and 𝑃 = 0.009) carriers were both less frequent among
cases than controls, suggesting a dominant effect of the C
allele. Overall, C carriers (either TC or CC) were associated
with a lower GC risk when compared to those carrying the
TT genotype (adjusted OR = 0.55, 95% CI = 0.37–0.83, and
𝑃 = 0.004). Conversely, the genotype and allele frequencies of
locus rs2293152 did not show a significant difference between
GC cases and controls.
3.3. Stratified Analysis of STAT3 Polymorphism rs744166
and GC Risk. We further evaluated the association between
genotypes of these two selected SNPs of STAT3 and GC risk
by stratified subgroups of age, sex, smoking status, drinking
consumption, and family history of cancer, assuming a
dominant geneticmodel (Table 3). Stratified analysis revealed
that a decreased risk of GC was associated with the rs744166
TC+CC genotypes among subjects 60 years of age and older
(adjusted OR = 0.49, 95%CI = 0.26–0.90, and𝑃 = 0.021), but
not in subjects less than 60 years old. Additionally, TC+CC
genotypes were associated with a decreased risk of GC in
male subjects (adjusted OR = 0.54, 95% CI = 0.32–0.88, and
𝑃 = 0.014), whereas the association was not statistically
significant in female subjects. When stratified by smoking
status, the C carriers were found to be significantly associated
with GC (adjusted OR = 0.54, 95% CI = 0.32–0.93, and 𝑃 =
0.026) compared to the TT genotype carriers in smokers.
Likewise, drinkers with C carriers showed a significantly
decreased risk ofGC (adjustedOR=0.38, 95%CI = 0.21–0.70,
and𝑃 = 0.002), compared to those carrying the TT genotype.
Stratification by family history of cancer revealed a significant
association of TC+CC genotypes and the risk of GC (adjusted
OR = 0.55, 95% CI = 0.36–0.85, and 𝑃 = 0.007) in subjects
without family history of cancer, whereas the association was
not statistically significant in subjects with family history of
cancer. Conversely, we observed no statistical significance
between the rs2293152 gene polymorphism and the risk ofGC
(data not show).
3.4. Combined Effects of STAT3 Polymorphisms on GC Risk.
Table 4 shows analyses of interaction and combination effects
between genotypes and environmental exposures for the risk
of GC. We found that these two SNPs effects were additive to
the effects of environmental factors without any interaction
between them in the susceptibility to GC.
For rs744166, significant combination effects between
high intake of chicken (≥average 2 times/week) and fresh
fruit (≥average 2 times/week) and the TC+CC genotypes
were observed (chicken: OReg = 0.25 and 95% CI =
0.13–0.48; fresh fruit: OReg = 0.34 and 95% CI = 0.19–
0.61). Consumption of seafood (≥average 2 times/week) and
using a refrigerator to store food were associated with a
decreased risk of GC in subjects with a C allele or TT
genotype. On the contrary, long-term irregular eating habits
were associated with an increased risk of GC. Additionally,
no statistically significant interactions or combination effects
were observed between consumption of pork, preference
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Table 2: Genotype and allele frequencies of STAT3 polymorphisms and their associations with GC risk.
Genotypes Cases (𝑁 = 209) Controls (𝑁 = 294) OR (95% CI) 𝑃 value ORadj (95% CI)
a
𝑃 value
Number (%) Number (%)
rs2293152
GG 56 (26.8) 74 (25.2) 1.00 1.00
CG 94 (45.0) 157 (53.4) 0.79 (0.51–1.22) 0.287 0.87 (0.54–1.41) 0.540
CC 59 (28.2) 63 (21.4) 1.24 (0.75–2.03) 0.400 1.40 (0.81–2.42) 0.330
CG/CC 0.92 (0.61–1.38) 0.681 1.03 (0.66–1.62) 0.893
rs744166
TT 101 (48.3) 107 (36.4) 1.00 1.00
TC 89 (42.6) 142 (48.3) 0.66 (0.45–0.97) 0.035 0.60 (0.39–0.92) 0.020
CC 19 (9.1) 45 (15.3) 0.45 (0.25–0.82) 0.009 0.41 (0.21–0.80) 0.009
TC/CC 0.61 (0.43–0.88) 0.008 0.55 (0.37–0.83) 0.004
OR: odds ratio; CI: confidence interval.
aAdjusted for age, sex, smoking, drinking, BMI, and family history of cancer.
for hot food, and the rs744166 polymorphism on GC risk.
Moreover, the combination effects of rs2293152 and environ-
mental factors are almost identical to rs744166 (data shown in
Table 4).
4. Discussion
GC is an inflammation-related disease that induces massive
cytokine release, including IL-1, IL-6, IL-12, and TNF-𝛼 [26–
28]. STAT3, which transmits a wide range of cytokines,
was first identified in 1994 as an IL-6-activated acute-phase
response factor (APRF) [29]. It is frequently reported to be
overexpressed in various cancers [30] and has, therefore,
been recognized as an oncogene. Several STAT3 SNPs were
reported to be significantly associated with cervical cancer,
nonsmall cell lung cancer, metastatic renal cell carcinoma,
prostate cancer, and hepatocellular cancer. These include
rs2293152, rs744166, rs4769793, rs4796793, and rs7211777 [4,
20, 23, 24]. Moreover, rs744166 was also reported to have a
significant association with Crohn’s disease [25, 31]. Based on
previous studies, our case-control study detected the effect
of STAT3 rs2293152 and rs744166 gene polymorphisms on
GC. In our study, we found that subjects with the minor
C allele of rs744166 had a decreased risk of developing GC
compared to the common genotype in a Chinese popula-
tion. However, we did not find any significant association
between the rs2293152 gene polymorphism and risk of
GC.
Recently, increasing evidence shows that polymorphisms
of the STAT3 gene are associatedwith various diseases [21, 31–
33]. In a large German cohort study, a significant association
was observed between theminor allele of STAT3 rs744166 and
Crohn’s disease (OR = 0.83, 95% CI = 0.688–0.998, and 𝑃 =
0.04) [31]. Similarly, Danoy et al. identified STAT3 rs744166
as a susceptible loci of ankylosing spondylitis (OR = 0.84,
95% CI = 0.77–0.91, and 𝑃 = 2.6 × 10−5) in a population of
white European ancestry from the UK, USA, Canada, and
Australia [34]. Moreover, Jiang et al. reported that the minor
allele of rs744166 significantly decreased the risk of nonsmall
cell lung cancer in a Chinese population [20]. These findings
on the rs744166 C allele and the decreased risk of GC in the
present study are consistent with reported results. However,
the results of our study on rs2293152 show variation from
previous research. A Chinese study involving 1,021 hepatocel-
lular carcinoma patients and 1,012 healthy controls found that
rs2293152 (GG versus CC) was significantly associated with
risk of hepatocellular carcinoma [24]. Yet, other researches
on familial breast cancer and nonsmall cell lung cancer did
not show associations of rs2293152 [20, 33] and neither did
our study. These differences could potentially be the result
of varying environmental backgrounds, ethnic groups, and
sample sizes.
Furthermore, our present study revealed a decreased
effect with the C allele of rs744166 in subgroups of males,
smokers, and drinkers. Stratified analysis suggested that
the association between the C allele of rs744166 and the
risk of GC was more profound in males than females. A
previous study reported that noncardia cancer was more
common in males than females by a ratio of approxi-
mately 2 : 1, and gastric cardia cancer had a ratio of nearly
4.1 : 1 in a Chinese population [35]. Our data suggests that
STAT3 polymorphism may play an important role in males
with GC. Smoking, which generates reactive oxygen species
production and induces DNA adducts that may lead to
mutations and thus the initiation of carcinogenesis, has been
confirmed to be an independent risk factor of GC [36, 37].
Meanwhile, for drinking, previous reports suggested that
alcohol consumption is one of the risk factors of GC as
well [38, 39]. In our present study, it is also suggested that
the influence of the C allele of rs744166 on GC was more
critical in subgroups of smokers and drinkers.Theunderlying
mechanism involved in the association between STAT3 and
smoking and drinking is not clear. It is likely that smoking
BioMed Research International 5
Table 3: Stratified analyses of rs744166 genotypes betweenGC cases
and controls.
Variables rs744166 𝑃 value
TT TC+CC
Age (years)
<60
Cases/controls 48/61 58/101
ORadj (95% CI)
a 1.00 0.64 (0.37–1.13) 0.127
≥60
Cases/controls 53/46 50/86
ORadj (95% CI)
a 1.00 0.49 (0.26–0.90) 0.021
Sex
Male
Cases/controls 77/73 81/128
ORadj (95% CI)
a 1.00 0.54 (0.32–0.88) 0.014
Female
Cases/controls 24/34 27/59
ORadj (95% CI)
a 1.00 0.63 (0.28–1.40) 0.254
Smoking statusb
Never
Cases/controls 32/58 39/96
ORadj (95% CI)
a 1.00 0.56 (0.29–1.07) 0.081
Ever
Cases/controls 68/48 69/91
ORadj (95% CI)
a 1.00 0.54 (0.32–0.93) 0.026
Alcohol consumption
Nondrinkers
Cases/controls 39/69 46/103
ORadj (95% CI)
a 1.00 0.73 (0.40–1.31) 0.288
Drinkers
Cases/controls 62/38 62/84
ORadj (95% CI)
a 1.00 0.38 (0.21–0.70) 0.002
Family history of cancerbc
No
Cases/controls 76/102 81/178
ORadj (95% CI)
a 1.00 0.55 (0.36–0.85) 0.007
Yes
Cases/controls 22/4 25/8
ORadj (95% CI)
a 1.00 0.50 (0.11–2.28) 0.371
OR: odds ratio; CI: confidence interval.
aAdjusted for age, sex, smoking, drinking, BMI, and family history of cancer.
bMissing data: smoking: 2; family history of cancer: 7.
cFamily history of cancer: gastric, esophageal, liver, colorectal, and other
cancers.
and drinking might significantly induce STAT3 expression,
and it is possible that the C allele of rs744166 leads to
a higher basal expression level of STAT3 under unnormal
circumstances. Therefore, the subjects carrying the C allele
of rs744166 might not have decreased GC risk under normal
conditions but might have a reduced risk when exposed to
tobacco and alcohol that might induce STAT3 expression in
response.
Interestingly, we found that the influence of C allele of
rs744166 disappeared in the subjects with family history,
although it existed in all study subjects. Positive family
history was reported as a strong and consistent risk factor
for GC due to the combination result of a number of alleles
[40, 41]. Therefore, the decreased risk effect of rs744166 in
subjects with family history may be overwhelmed by the
role of familial aggregation, which may partly contribute to
the results we observed. Small sample size in the subgroups
may also account for the variation seen between studies.
Therefore, further studies should be conducted with a larger
sample size.
Single SNPs in low-penetrance genes are unlikely to
significantly affect susceptibility to cancer, but combination
effects may exist [42, 43]. In our study, significant combina-
tion effects were observed with environmental factors. Fruits
are high in antioxidants, phytosterols, and other substances
that may inhibit carcinogenesis by free-radical quenching
or by blocking the formation of N-nitroso compounds.
Epidemiologic studies have found that fruits are associ-
ated with a decreased risk of GC [44]. In this study, we
found a significant combination effect between fresh fruit
consumption and the C allele of rs744166 in decreasing
the risk of GC. Meanwhile, lifestyle choices such as long-
term irregular eating habits and the methods of storing
food may also be important factors for GC in this Chinese
population. To our knowledge, this is the first study to be
concerned with the interaction between the STAT3 gene
polymorphisms and environmental factors for the risk of
GC; further studies are needed to confirm this phenomena
and a mechanistic explanation for our findings needs to be
explored.
Some limitations in our study need to be addressed. First,
the relatively small sample size may reduce the statistical
power in stratified analysis. The second limitation was an
inevitable recall bias during data collection in regard to
environmental factors, althoughmeasureswere taken tomin-
imize this bias. Third, we adopted a frequency questionnaire
to collect information about dietary intake that did not take
into consideration the amounts of food being consumed.
Therefore, the questionnaire had limited power to detect
precise gene-dietary interactions. Finally, H. pylori is an
independent risk factor for GC that we did not explore due
to ethical considerations. These related issues will need to be
addressed in our future studies.
In conclusion, our data provided the first evidence that
the C allele of STAT3 rs744166 is associated with decreased
GC risk in a Chinese population. The minor C allele of
rs744166 may correlate with STAT3 expression and thus
exert a protective effect on GC development. Additional
large-scale, well-designed studies that include environmental
factors are required to further validate the role of STAT3 gene
polymorphisms in GC risk.
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